Tag: Ruthigen

Finance

Hot News: Banco Bradesco S.A. (NYSE:BBD), Lime Energy Co. (NASDAQ:LIME), Ruthigen, Inc. (NASDAQ:RTGN), 3D Systems Corporation (NYSE:DDD), Helix Energy Solutions Group, Inc. (NYSE:HLX)

Banco Bradesco S.A. (NYSE:BBD) announced a cash dividend. Payment of $0.008913 per share is scheduled to be paid on November 10, 2014. Shareholders who purchased BBD stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an -2.74% decrease from the prior month. At the current stock price of $14.25, the dividend yield is .75%. Banco Bradesco S.A. (NYSE:BBD) belongs … Continue reading Hot News: Banco Bradesco S.A. (NYSE:BBD), Lime Energy Co. (NASDAQ:LIME), Ruthigen, Inc. (NASDAQ:RTGN), 3D Systems Corporation (NYSE:DDD), Helix Energy Solutions Group, Inc. (NYSE:HLX)

John Meady
Finance

Why Making Dramatic Moves : Ruthigen, Inc. (NASDAQ:RTGN), Rite Aid Corporation (NYSE:RAD), ION Geophysical Corporation (NYSE:IO), Guidance Software, Inc. (NASDAQ:GUID), Graham (NYSE:GHM)

Ruthigen Inc (NASDAQ:RTGN) in the last week of August announced that it had received approval for Phase I/II Study. It can begin enrollment of patients in its trial meant to test its anti-infection drug RUT58-60. It has already completed a 21-day skin irritation study conducted on 36 human participants, and now will start with double-blind, multi-centered and randomized trial. The enrollment for patients will start … Continue reading Why Making Dramatic Moves : Ruthigen, Inc. (NASDAQ:RTGN), Rite Aid Corporation (NYSE:RAD), ION Geophysical Corporation (NYSE:IO), Guidance Software, Inc. (NASDAQ:GUID), Graham (NYSE:GHM)

Jayne Crisman
Finance

Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded volume was 43.6K shares in the last session and the … Continue reading Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Chris Lewis